Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$11.74−1.01 (-7.92%)
Close on Nov 17, 2026Market cap $79.70MP/E –Yield –
Eloxx Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Eloxx Pharmaceuticals's price to sales ratio was 0.0× on Feb 27, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 0.0× | −0.0 |
| 2025 | Dec 31, 2025 | 0.0× | – |
See a number that looks wrong?